HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumer Brands Should Be Forces For Good, But Growth First – P&G’s Marc Pritchard

Executive Summary

Unlike others in the industry, and arguably P&G in recent memory, P&G brands are putting growth before good in the “virtuous circle” equation as competitors lose sight of innovation and macroeconomic conditions worsen globally.

You may also be interested in...



In-House Advertising For Secret Shows New Model For Marketing P&G Brands

Gillette’s New ‘Best Men Can Be’ Ad Goes Viral, Drawing Mixed Praise, Boycott Threats

Gillette’s polarizing new video, which challenges men to “do more” to address behavior broadly painted as toxic masculinity, has elicited fervid reactions from all corners of the Internet. Whether the P&G brand’s boldness pays off remains to be seen, but it adds fuel to a growing debate: Should brands insert themselves into today’s highly politicized climate, and can they afford not to?

P&G Talks Digital, Shave Biz Strategy In Light Of Unilever’s DSC Buy

Many emerging e-commerce brands may merely be flash-in-the-pan phenomena, but P&G is investing significantly in e-commerce and digital marketing to “win mobile back,” according to CEO David Taylor. The firm also will continue to strengthen the mid and value tiers of its shave business, he said during a Q4 earnings call in which Unilever’s Dollar Shave Club acquisition was on a number of analysts’ minds.

Topics

Latest News
UsernamePublicRestriction

Register

RS152656

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel